La gran paradoja

Coates LC, Anderson RR, Fitzgerald O, Gottlieb AB, Kelly SG, Lubrano E, et al. Clues to the pathogenesis of psoriasis and psoriatic arthritis from imaging: a literature review. J Rheumatol. 2008;35(7):1438-42.

Nickoloff BJ. Creation of psoriatic plaques: the ultimate tumor suppressor pathway. A new model for an ancient T-cell-mediate skin disease. Viewpoint. J Cutan Pathol. 2001;28(2):57-64.

https://doi.org/10.1034/j.1600-0560.2001.280201.x

Chaturvedi V, Cesnjaj M, Bacon P, Panella J, Choubey D, Diaz MO, et al. Role of INK4a/Arf locus-encoded senescent checkpoints activated in normal and psoriatic keratinocytes. Am J Pathol. 2003;162(1):161-70.

https://doi.org/10.1016/S0002-9440(10)63807-2

Zenz R, Eferl R, Scheinecker C, Redlich K, Smolen J, Schonthaler HB, et al. Activator protein 1 (Fos/Jun) functions in inflammatory bone and skin disease. Arthritis Res Ther. 2008;10(1):201.

https://doi.org/10.1186/ar2338

Zenz R, Waqner EF. Jun signalling in the epideremis: From developmental defects to psoriasis and skin tumors. Int J Biochem Cell Biol. 2006;38(7):1043-9.

https://doi.org/10.1016/j.biocel.2005.11.011

Serznig P, Seifert M, Tilgen W, Reichrath J. Peroxisome proliferatoractivated receptors (PPARs) and the human skin: importance of PPARs in skin physiology and dermatologic diseases. Am J Clin Dermatol. 2008;9(1):15-31.

https://doi.org/10.2165/00128071-200809010-00002

Njar VC, Gediva L, Purushottamachar P, Chopra P, Vasaitis TS, Khandelwal A, et al. Retinoic acid metabolism blocking agents (RAMBAs) for treatment of cancer and dermatological diseases. Bioorg Med Chem. 2006;14(13):4323-40.

https://doi.org/10.1016/j.bmc.2006.02.041

McCaffery P, Simons C. Prospective teratology of retinoic acid metabolic blocking agents (RAMBAs) and loss of CYP26 activity. Curr Pharm Des. 2007;13(29):3020-37.

https://doi.org/10.2174/138161207782110534

Thangapazham RL, Sharma A, Maheshwari RK. Beneficial role of curcumin in skin diseases. Adv Exp Med Biol. 2007;595:343-57.

https://doi.org/10.1007/978-0-387-46401-5_15

Hsu CH, Cheng AL. Clinical studies with curcumin. Adv Exp Med Biol. 2007;595:471-80.

https://doi.org/10.1007/978-0-387-46401-5_21

Boyd AS. Thiazolidinediones in dermatology. Int J Dermatol. 2007;46(6):557-63.

https://doi.org/10.1111/j.1365-4632.2007.03273.x

Reichrath J, Lehmann B, Carlberg C, Varani J, Zouboulis CC. Vitamins as hormones. Horm Metab Res. 2007;39(2):71-84.

https://doi.org/10.1055/s-2007-958715

Paghdal KV, Schwartz RA. Sirolimus (rapamycin): from the soil of Easter Island to a bright future. JAm Acad Dermatol. 2007;57(6):1046-50.

https://doi.org/10.1016/j.jaad.2007.05.021

Sano S, Chan KS, DiGiovanni J. Impact of Stat3 activation upon skin biology: a dichotomy of its role between homeostasis and diseases. J Dermatol Sci. 2008;50(1):1-14.

https://doi.org/10.1016/j.jdermsci.2007.05.016

Kamstrup M, Faurschou A, Gniadecki R, Wulf HC. Epidermal stem cells-role in normal, wounded adn pathological psoriatic and cancer skin. Curr Stem Cell Res Ther. 2008;3(2):146-50.

https://doi.org/10.2174/157488808784223087

Gómez AA. Psoriasis y cancer. Rev Colomb Cancerol. 2008;12(3)150-155.